tiprankstipranks
NanoViricides (NNVC)
NYSE MKT:NNVC
Holding NNVC?
Track your performance easily

NanoViricides (NNVC) Financial Statements

467 Followers

NanoViricides Financial Overview

NanoViricides's market cap is currently ―. The company's EPS TTM is $-0.758; its P/E ratio is -1.75; NanoViricides is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.10M$ -2.36M$ -1.85M$ -2.10M$ -1.93M
EBITDA$ -2.90M$ -2.17M$ -1.85M$ -1.91M$ -1.74M
Net Income Common Stockholders$ -3.10M$ -2.36M$ -1.85M$ -2.11M$ -1.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.87M$ 4.80M$ 3.26M$ 5.25M$ 6.97M
Total Assets$ 11.74M$ 12.82M$ 11.46M$ 13.40M$ 15.42M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 1.50M
Net Debt$ -3.87M$ -4.80M$ -3.26M$ -5.25M$ -5.47M
Total Liabilities$ 283.29K$ 1.36M$ 813.34K$ 951.07K$ 2.45M
Stockholders Equity$ 10.11M$ 11.46M$ 10.65M$ 12.45M$ 12.97M
Cash Flow-
Free Cash Flow$ -2.65M$ -1.60M-$ -1.72M$ -1.18M
Operating Cash Flow$ -2.60M$ -1.50M$ -1.90M$ -1.72M$ -1.17M
Investing Cash Flow$ -46.76K$ -98.16K$ -44.63K$ -5.47K$ -8.29K
Financing Cash Flow$ 1.71M$ 3.12M---
Currency in USD

NanoViricides Earnings and Revenue History

NanoViricides Debt to Assets

NanoViricides Cash Flow

NanoViricides Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis